These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28657764)

  • 1. Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D.
    Duncan JA; Nahirniak S; Onell R; Clarke G
    Immunohematology; 2017 Jun; 33(2):60-63. PubMed ID: 28657764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cases of RhD variants RhD*DAU2/DAU6 and RhD*weak D type 4.1 in pregnant women in Saudi Arabia.
    Owaidah A; Aljuhani K; Albasri J; Alsulmi E; Alsaihati T; Alzahrani F
    Acta Biomed; 2023 Mar; 94(S1):e2023080. PubMed ID: 36883669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
    Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
    Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
    Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
    Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization.
    Horn TN; Keller J; Keller MA; Klinger L
    Immunohematology; 2020 Dec; 36(4):146-151. PubMed ID: 33544620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services.
    Ramsey G; Park YA; Eder AF; Bobr A; Karafin MS; Karp JK; King KE; Pagano MB; Schwartz J; Szczepiorkowski ZM; Souers RJ; Thomas L; Delaney M
    Arch Pathol Lab Med; 2023 Jan; 147(1):71-78. PubMed ID: 35486492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion support during childbirth for a woman with anti-U and the
    Yin Q; Srivastava K; Brust DG; Flegel WA
    Immunohematology; 2021 Mar; 37(1):1-4. PubMed ID: 33962485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
    Turley E; McGowan EC; Hyland CA; Schoeman EM; Flower RL; Skoll A; Delisle MF; Nelson T; Clarke G; Au N
    Transfusion; 2018 Oct; 58(10):2260-2264. PubMed ID: 30222865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.
    Stegmann TC; Veldhuisen B; Bijman R; Thurik FF; Bossers B; Cheroutre G; Jonkers R; Ligthart P; de Haas M; Haer-Wigman L; van der Schoot CE
    Br J Haematol; 2016 May; 173(3):469-79. PubMed ID: 27018217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
    Londero D; Monge J; Hellberg A
    Vox Sang; 2020 Apr; 115(3):241-248. PubMed ID: 31912520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic RHD genotyping in Brazilians reveals a high frequency of partial D in transfused patients serologically typed as weak D.
    Miranda MR; Dos Santos TD; Castilho L
    Transfus Apher Sci; 2021 Dec; 60(6):103235. PubMed ID: 34389204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).
    Jeong IH; Yu S; Kim TY; Oh SY; Cho D
    Ann Lab Med; 2024 Jul; 44(4):307-313. PubMed ID: 38384203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
    Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
    Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
    Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.